INSPIRE Diabetes Study: Basal Bolus Insulin as Primary Treatment of Type 2 Diabetes

NCT01087567 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Intensive insulin
DRUG: Routine Care

Sponsor

Ohio University

Collaborators

[object Object]